COLLIGO-HCM: A Multinational Observational Study of the Real-World Effectiveness of Mavacamten Among Patients With Symptomatic Obstructive Hypertrophic Cardiomyopathy (oHCM) (clinicaltrials.gov) - Oct 1, 2026 - P=N/A | N=331 | Active, not recruiting | Sponsor: Bristol-Myers Squibb | Trial completion date: Jun 2026 ➔ Dec 2026
Real-world evidence • Trial completion date • Cardiomyopathy • Cardiovascular • Hypertrophic Cardiomyopathy • Obstructive Hypertrophic Cardiomyopathy • CYP2C19
|